Literature DB >> 10073283

Escherichia coli O157:H7 gastroenteritis and the hemolytic uremic syndrome: an emerging infectious disease.

R E Besser1, P M Griffin, L Slutsker.   

Abstract

Escherichia coli O157:H7 is an increasingly common cause of a variety of illnesses, including bloody diarrhea and the hemolytic uremic syndrome. This emerging infectious agent was first identified in 1982 and has been isolated with increasing frequency since then. This chapter reviews the epidemiology, clinical spectrum, diagnosis, treatment, and prevention of infections with E. coli O157:H7.

Entities:  

Mesh:

Year:  1999        PMID: 10073283     DOI: 10.1146/annurev.med.50.1.355

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  49 in total

1.  Rapid detection of Shiga toxin-producing bacteria in feces by multiplex PCR with molecular beacons on the smart cycler.

Authors:  Simon D Bélanger; Maurice Boissinot; Christian Ménard; François J Picard; Michel G Bergeron
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Seasonal variation of HUS occurrence and VTEC infection in children with acute diarrhoea from Argentina.

Authors:  M A Rivero; J A Passucci; E M Rodríguez; A E Parma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-22       Impact factor: 3.267

3.  Bacterial Infections of the Colon.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-06

4.  Inhibition of development of Shiga toxin-converting bacteriophages by either treatment with citrate or amino acid starvation.

Authors:  Bożena Nejman-Faleńczyk; Piotr Golec; Monika Maciąg; Alicja Wegrzyn; Grzegorz Węgrzyn
Journal:  Foodborne Pathog Dis       Date:  2011-11-02       Impact factor: 3.171

5.  Genome signatures of Escherichia coli O157:H7 isolates from the bovine host reservoir.

Authors:  Mark Eppinger; Mark K Mammel; Joseph E Leclerc; Jacques Ravel; Thomas A Cebula
Journal:  Appl Environ Microbiol       Date:  2011-03-18       Impact factor: 4.792

6.  Biotic and abiotic factors influencing in vitro growth of Escherichia coli O157:H7 in ruminant digestive contents.

Authors:  Frédérique Chaucheyras-Durand; Jordan Madic; Florent Doudin; Christine Martin
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

7.  Use of in vivo-induced antigen technology for identification of Escherichia coli O157:H7 proteins expressed during human infection.

Authors:  Manohar John; Indira T Kudva; Robert W Griffin; Allen W Dodson; Bethany McManus; Bryan Krastins; David Sarracino; Ann Progulske-Fox; Jeffrey D Hillman; Martin Handfield; Phillip I Tarr; Stephen B Calderwood
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

8.  Effects of exogenous melatonin and tryptophan on fecal shedding of E. coli O157:H7 in cattle.

Authors:  Tom S Edrington; Todd R Callaway; Dennis M Hallford; Liang Chen; Robin C Anderson; David J Nisbet
Journal:  Microb Ecol       Date:  2007-09-15       Impact factor: 4.552

Review 9.  Future perspectives, applications and challenges of genomic epidemiology studies for food-borne pathogens: A case study of Enterohemorrhagic Escherichia coli (EHEC) of the O157:H7 serotype.

Authors:  Mark Eppinger; Thomas A Cebula
Journal:  Gut Microbes       Date:  2014-09-01

Review 10.  Progress towards recombinant anti-infective antibodies.

Authors:  Jennifer C Pai; Jamie N Sutherland; Jennifer A Maynard
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.